Search research articles
Contact Us
Filters
Showing results (1151-1160 of 1,160) with videos related to
Page
of 116
Sort By:
You have reached the last page of results.
This site can display upto 1,160 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 1, 2019
ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathways
Hye Jeong Lee, Jiyoung Moon, InHyeok Chung, et al.
Endocrinology and Metabolism (Seoul, Korea)
|
March 27, 2019
Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
Sang Ouk Chin, Cheol Ryong Ku, Byung Joon Kim, et al.
Journal of Korean Medical Science
|
February 6, 2009
The mildly elevated serum bilirubin level is negatively associated with the incidence of end stage renal disease in patients with IgA nephropathy
Ho Jun Chin, Hyun Jin Cho, Tae Woo Lee, et al.
Diabetes & Metabolism
|
March 11, 2023
Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study
Kyung-Soo Kim, Kyung Ah Han, Tae Nyun Kim, et al.
Endocrinology and Metabolism (Seoul, Korea)
|
July 4, 2020
Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology
Jung Hee Kim, Hyun Wook Chae, Sang Ouk Chin, et al.
EMBO Molecular Medicine
|
February 13, 2025
Portimine A toxin causes skin inflammation through ZAKα-dependent NLRP1 inflammasome activation
Léana Gorse, Loïc Plessis, Stephen Wearne, et al.
Cell Reports
|
July 7, 2015
Recurrent Fusion Genes in Gastric Cancer: CLDN18-ARHGAP26 Induces Loss of Epithelial Integrity
Fei Yao, Jaya P Kausalya, Yee Yen Sia, et al.
Diabetes & Metabolism Journal
|
May 19, 2024
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial
Jie-Eun Lee, Seung Hee Yu, Sung Rae Kim, et al.
Endocrinology and Metabolism (Seoul, Korea)
|
August 22, 2024
Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)
Nam Hoon Kim, Juneyoung Lee, Suk Chon, et al.
Cardiovascular Diabetology
|
June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
Jean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Page
of 116
Search research articles
Search
Showing results (1151-1160 of 1,160) with videos related to
Sort By:
Page
of 116
You have reached the last page of results.
This site can display upto 1,160 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 1, 2019
ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathways
Hye Jeong Lee, Jiyoung Moon, InHyeok Chung, et al.
Endocrinology and Metabolism (Seoul, Korea)
|
March 27, 2019
Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
Sang Ouk Chin, Cheol Ryong Ku, Byung Joon Kim, et al.
Journal of Korean Medical Science
|
February 6, 2009
The mildly elevated serum bilirubin level is negatively associated with the incidence of end stage renal disease in patients with IgA nephropathy
Ho Jun Chin, Hyun Jin Cho, Tae Woo Lee, et al.
Diabetes & Metabolism
|
March 11, 2023
Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study
Kyung-Soo Kim, Kyung Ah Han, Tae Nyun Kim, et al.
Endocrinology and Metabolism (Seoul, Korea)
|
July 4, 2020
Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology
Jung Hee Kim, Hyun Wook Chae, Sang Ouk Chin, et al.
EMBO Molecular Medicine
|
February 13, 2025
Portimine A toxin causes skin inflammation through ZAKα-dependent NLRP1 inflammasome activation
Léana Gorse, Loïc Plessis, Stephen Wearne, et al.
Cell Reports
|
July 7, 2015
Recurrent Fusion Genes in Gastric Cancer: CLDN18-ARHGAP26 Induces Loss of Epithelial Integrity
Fei Yao, Jaya P Kausalya, Yee Yen Sia, et al.
Diabetes & Metabolism Journal
|
May 19, 2024
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial
Jie-Eun Lee, Seung Hee Yu, Sung Rae Kim, et al.
Endocrinology and Metabolism (Seoul, Korea)
|
August 22, 2024
Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)
Nam Hoon Kim, Juneyoung Lee, Suk Chon, et al.
Cardiovascular Diabetology
|
June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
Jean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Page
of 116